World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
9475
World Ranking
14047
National Ranking
5924

Overview

Martin D. McCarter is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily spans the field of Medicine with a focus on Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology, and Molecular Biology. Within these fields, their work addresses various aspects of cancer and immunotherapy.

The scientist's main topics of research include:

  • Cancer Immunotherapy and Biomarkers
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics

Among recent publications, several key papers include:

  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021 (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022 (2022), Journal of the National Comprehensive Cancer Network
  • Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling (2021), Immunobiology
  • Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy (2020), Cancers

Frequent co-authors collaborating with Martin D. McCarter include Michelle L. Churchman, Ahmad A. Tarhini, Ana Gleisner, Richard P. Tobin, and Aik Choon Tan.

Their work has appeared extensively in a number of publication venues, notably:

  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Cancer Research

Best Publications

  • Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

    Christopher L. Corless;Karla V. Ballman;Cristina R. Antonescu;Violetta Kolesnikova

  • Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients

    Tullia C. Bruno;Peggy J. Ebner;Brandon L. Moore;Olivia G. Squalls

  • ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets

    Yuchun Luo;Katiuscia Dallaglio;Ying Chen;William A. Robinson

  • CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue

    Elizabeth Connick;Teresa Mattila;Joy M. Folkvord;Rick Schlichtemeier

  • Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

    Quisette P. Janssen;Stefan Buettner;Mustafa Suker;Berend R. Beumer

  • Post-discharge venous thromboembolism after cancer surgery: Extending the case for extended prophylaxis

    Ryan P. Merkow;Karl Y. Bilimoria;Karl Y. Bilimoria;Martin D. McCarter;Mark E. Cohen

  • Interim analysis of a prospective phase I/II trial of SBRT for liver metastases

    Brian D. Kavanagh;Tracey E. Schefter;Higinia R. Cardenes;Volker W. Stieber

  • Soft Tissue Sarcoma, Version 1.2021: Featured updates to the NCCN guidelines

    Margaret von Mehren;John M. Kane;Marilyn M. Bui;Edwin Choy

  • Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

    Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Christopher Corless

  • Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner

    Jason T. White;Eric W. Cross;Matthew A. Burchill;Thomas Danhorn

  • Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

    Martin D. McCarter;Cristina R. Antonescu;Karla V. Ballman;Robert G. Maki

  • Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.

    Richard P. Tobin;Kimberly R. Jordan;William A. Robinson;William A. Robinson;Dana Davis

  • Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.

    Sachin Wani;Bashar Qumseya;Shahnaz Sultan

  • Dominance of T-helper 2-type cytokines after severe injury.

    Vivian E. Mack;Martin D. McCarter;Hassan A. Naama;Steve E. Calvano

  • Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection.

    Stephanie M Dillon;Kathryn B Robertson;Samuel C Pan;Samantha Mawhinney

  • Long-term outcome of perianal Paget's disease.

    Martin D. McCarter;Stuart H. Q. Quan;Klaus Busam;Philip P. Paty

  • Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

    C. Preston Neff;Matthew E. Rhodes;Kathleen L. Arnolds;Colm B. Collins

  • Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial

    Kazuo Koyanagi;Anton J. Bilchik;Sukamal Saha;Roderick R. Turner

  • Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

    Jennifer D. Hintzsche;Nicholas T. Gorden;Carol M. Amato;Jihye Kim;Jihye Kim

  • Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients

    Kimberly R. Jordan;Rodabe N. Amaria;Oscar Ramirez;Eryn B. Callihan

Frequent Co-Authors

Richard D. Schulick
Richard D. Schulick University of Colorado Anschutz Medical Campus
Rene Gonzalez
Rene Gonzalez University of Colorado Anschutz Medical Campus
Cara C. Wilson
Cara C. Wilson University of Colorado Anschutz Medical Campus
Sachin Wani
Sachin Wani University of Colorado Anschutz Medical Campus
Wells A. Messersmith
Wells A. Messersmith University of Colorado Boulder
Brent E. Palmer
Brent E. Palmer University of Colorado Denver
Elizabeth Connick
Elizabeth Connick University of Arizona
Virginia F. Borges
Virginia F. Borges University of Colorado Boulder
Karl Y. Bilimoria
Karl Y. Bilimoria Indiana University
David J. Bentrem
David J. Bentrem Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to diverse careers beyond the lab. One growing area is health information management, where professionals ensure accurate medical records and data security. If you’re interested in an affordable path, consider a him degree, which is offered online by many universities for flexible study options.

Medical coding is another in-demand field that offers stable opportunities for Biology and Biochemistry graduates. Learning about medical.coding salary can help you understand the earning potential in this essential profession. With the increasing use of electronic health records, the medical coding job outlook remains very positive, making this a desirable option for those wanting to enter the healthcare industry without direct patient care.

For those passionate about health and nutrition, pursuing a masters in nutrition online can lead to advanced roles in dietetics, wellness coaching, or health education. With the availability of reputable and affordable online programs, students can further specialize while balancing studies with other responsibilities.

Best Scientists Citing Martin D. McCarter

Trending Scientists

Recently Published Articles